The two-day international conference ‘New approaches for prioritisation and assessment of the risks of pharmaceuticals in the environment’ will mark the end of the IMI-funded project ‘Intelligence-led assessment of pharmaceuticals in the environment’ (iPiE). The conference will take place on 24-25 June 2019 at the University of York (UK). It will provide an overview on […]
The project Intelligence-led assessment of pharmaceuticals in the environment (iPiE) will be presented at the SETAC Europe Annual Meeting in Helsinki, at a symposium organised by the SETAC Europe Pharmaceutical Interest Group. The symposium will take place on Sunday, 26 May 2019 (13:00 – 17:30). Its aim is to present the iPiE project in detail […]
ECT is involved in the project ‘Intelligence-led assessment of pharmaceuticals in the environment’ (iPiE). The iPiE project contributes to developing frameworks for intelligence-based environmental testing of pharmaceuticals and for prioritising legacy pharmaceuticals for targeted environmental risk assessment and environmental (bio-) monitoring. The current iPiE newsletter (Newsletter No 6) features an interview with Anja Coors, who […]
ECT Oekotoxikologie GmbH is a privately owned enterprise that was founded in 1993.
In compliance with Good Laboratory Practice (GLP), we perform standardised ecotoxicological tests in the laboratory as well as at semi-field and field level.
- New publication: Compartment‐specific screening tools for persistence – potential role and application in the regulatory context
- Conference ‘New approaches for prioritisation and assessment of the risks of pharmaceuticals in the environment’
- Presentation of the iPiE project at the SETAC Europe meeting
Find us at
ECT Oekotoxikologie GmbH
Böttgerstraße 2 – 14
65439 Flörsheim am Main
Phone: +49 6145 9564-0
Fax: +49 6145 9564-99